SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Booker T. Washington Synthetic CCD

PatientBooker T. Washington
Date of birth1967-04-05
IdentifiersMRN HR-NI017-SYN; SSN (made up) 000-17-2284
Document date2026-11-01
AuthorLorraine Whitfield, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Primary care visit for headaches, fatigue, and a very high blood pressure. Concerns: Frontal headaches every week or so, palpitations, and fatigue are cutting into his workday; Worried about blurred reading vision and getting up at night to urinate; Wants a plan that fits a heavy travel schedule. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Amlodipine 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-05-04activeS
Losartan 50 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-05-04 to 2026-05-11completedS
Losartan 100 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-05-11activeS
Dapagliflozin 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-05-11activeS
Chlorthalidone 25 mg oral tablet, one-half tablet (12.5 mg) by mouth dailyOne-half tablet by mouth dailyOral route2026-06-01activeS
Atorvastatin 20 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-05-04activeS

Procedures

ProcedureDatesStatusEvidence
12-lead electrocardiogram: sinus rhythm with left ventricular hypertrophy by voltage2026-05-04 to 2026-05-04completedS
Dilated funduscopic examination: arteriolar narrowing and arteriovenous nicking in both eyes; no hemorrhages, exudates, or papilledema2026-05-04 to 2026-05-04completedS
Renal ultrasound: both kidneys small (9.4 and 9.6 cm) and echogenic, without hydronephrosis2026-05-11 to 2026-05-11completedS
Transthoracic echocardiography: concentric left ventricular hypertrophy, ejection fraction 60 percent2026-05-11 to 2026-05-11completedS

Immunizations

DateVaccineStatusEvidence
2025-10-20Influenza vaccine, 2025-2026 seasoncompletedS
2026-05-11Pneumococcal conjugate vaccine PCV20completedS
2026-05-11Hepatitis B vaccine (HepB-CpG), dose 1 of 2completedS
2026-06-29Hepatitis B vaccine (HepB-CpG), dose 2 of 2completedS
2019-09-16Tdap vaccinecompletedS
2026-09-21Influenza vaccine, 2026-2027 seasoncompletedS
2026-09-21Recombinant zoster vaccine, dose 1 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1911Assault in New York City with two large scalp lacerations and a torn ear; recovered without apparent sequelaeD (CLM-0005)
1911Chronic indigestion, worse when traveling; several days of treatment at the Battle Creek Sanitarium in 1911D (CLM-0005)

Family History

RelativeConditionAge at deathEvidence
motherDied in Malden, West Virginia, in 1876 (other accounts give 1874); cause not recorded in the cited sourceD (CLM-0003)

Health Concerns

ConcernStatusEvidence
Frontal headaches every week or so, palpitations, and fatigue are cutting into his workdayactiveS
Worried about blurred reading vision and getting up at night to urinateactiveS
Wants a plan that fits a heavy travel scheduleactiveS

Assessment

Most recent measures: Sodium [Moles/volume] in Serum or Plasma 137 on 2026-08-10; Potassium [Moles/volume] in Serum or Plasma 4.7 on 2026-08-10; Carbon dioxide, total [Moles/volume] in Serum or Plasma 23 on 2026-08-10; Urea nitrogen [Mass/volume] in Serum or Plasma 37 on 2026-08-10; Creatinine [Mass/volume] in Serum or Plasma 2.4 on 2026-08-10; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 30 on 2026-08-10; Glucose [Mass/volume] in Serum or Plasma 94 on 2026-08-10; Calcium [Mass/volume] in Serum or Plasma 9.2 on 2026-10-26; Phosphate [Mass/volume] in Serum or Plasma 4 on 2026-10-26; Parathyrin.intact [Mass/volume] in Serum or Plasma 78 on 2026-10-26; Hemoglobin [Mass/volume] in Blood 12.8 on 2026-10-26; Ferritin [Mass/volume] in Serum or Plasma 210 on 2026-05-04; Iron saturation [Mass Fraction] in Serum or Plasma 26 on 2026-05-04; Thyrotropin [Units/volume] in Serum or Plasma 1.8 on 2026-05-04; Hemoglobin A1c/Hemoglobin.total in Blood 5.4 on 2026-05-04; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 138 on 2026-05-04; Albumin/Creatinine [Mass Ratio] in Urine 240 on 2026-10-26; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 2026-09-21; Kidney failure 2-year risk [Likelihood] by KFRE 6.5 on 2026-10-26; Kidney failure 5-year risk [Likelihood] by KFRE 18.8 on 2026-10-26; Left ventricular Ejection fraction 60 on 2026-05-11; Total score [AUDIT-C] 1 on 2026-09-21 [S]

Strengths and supports: Supports: spouse, adult children, and long-time colleagues who urged him to be seen [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Severe hypertension with hypertensive kidney disease; synthetic modern diagnosis linked to the documented 1915 blood pressure of 220/150activeconfirmed I12.9S — Synthetic active diagnosis for the teaching episode; the 1915 findings remain D and the retrospective diagnosis remains R.
Chronic kidney disease stage G3b A3 (severely increased albuminuria), attributed to hypertensive nephrosclerosisactiveconfirmed N18.32S — Synthetic diagnosis supported by small echogenic kidneys and albuminuria; linked to the documented 1915 diagnosis of Bright's disease.
Hypertensive retinopathy, both eyes, without papilledemaactiveconfirmed H35.033S — Synthetic funduscopic finding that echoes the documented failing vision.
Mild anemia of chronic kidney disease, iron replete; monitoractiveconfirmed D63.1S — Synthetic finding from the baseline hemoglobin and iron studies.
Hyperlipidemiaactiveconfirmed E78.5S — Synthetic finding from the baseline LDL cholesterol.
Acute lumbar muscle strain after lifting, resolved without NSAIDs or imagingresolvedconfirmed S39.012AS — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-04Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-05-04Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
2026-05-04Carbon dioxide, total [Moles/volume] in Serum or Plasma21mmol/L22-29 mmol/LLowS
2026-05-04Urea nitrogen [Mass/volume] in Serum or Plasma34mg/dL6-24 mg/dLHighS
2026-05-04Creatinine [Mass/volume] in Serum or Plasma2.1mg/dL0.74-1.35 mg/dLHighS
2026-05-04Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M36mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
2026-05-04Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
2026-05-04Calcium [Mass/volume] in Serum or Plasma9.1mg/dL8.6-10.3 mg/dLNormalS
2026-05-04Phosphate [Mass/volume] in Serum or Plasma4.2mg/dL2.5-4.5 mg/dLNormalS
2026-05-04Parathyrin.intact [Mass/volume] in Serum or Plasma92pg/mL15-65 pg/mLHighS
2026-05-04Hemoglobin [Mass/volume] in Blood12.6g/dL13.2-16.6 g/dLLowS
2026-05-04Ferritin [Mass/volume] in Serum or Plasma210ng/mL30-400 ng/mLNormalS
2026-05-04Iron saturation [Mass Fraction] in Serum or Plasma26%20-50%NormalS
2026-05-04Thyrotropin [Units/volume] in Serum or Plasma1.8m[IU]/L0.45-4.5 mIU/LNormalS
2026-05-04Hemoglobin A1c/Hemoglobin.total in Blood5.4%<=5.6%NormalS
2026-05-04Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation138mg/dL<=99 mg/dLHighS
2026-05-04Albumin/Creatinine [Mass Ratio] in Urine820mg/g<=30 mg/gHighS
2026-05-04Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-05-11Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
2026-05-11Potassium [Moles/volume] in Serum or Plasma4.6mmol/L3.5-5.1 mmol/LNormalS
2026-05-11Carbon dioxide, total [Moles/volume] in Serum or Plasma22mmol/L22-29 mmol/LNormalS
2026-05-11Urea nitrogen [Mass/volume] in Serum or Plasma36mg/dL6-24 mg/dLHighS
2026-05-11Creatinine [Mass/volume] in Serum or Plasma2.2mg/dL0.74-1.35 mg/dLHighS
2026-05-11Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M34mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
2026-05-11Glucose [Mass/volume] in Serum or Plasma95mg/dL70-99 mg/dLNormalS
2026-06-01Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
2026-06-01Potassium [Moles/volume] in Serum or Plasma4.9mmol/L3.5-5.1 mmol/LNormalS
2026-06-01Carbon dioxide, total [Moles/volume] in Serum or Plasma22mmol/L22-29 mmol/LNormalS
2026-06-01Urea nitrogen [Mass/volume] in Serum or Plasma38mg/dL6-24 mg/dLHighS
2026-06-01Creatinine [Mass/volume] in Serum or Plasma2.4mg/dL0.74-1.35 mg/dLHighS
2026-06-01Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M30mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
2026-06-01Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-06-29Sodium [Moles/volume] in Serum or Plasma135mmol/L135-145 mmol/LNormalS
2026-06-29Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2026-06-29Carbon dioxide, total [Moles/volume] in Serum or Plasma23mmol/L22-29 mmol/LNormalS
2026-06-29Urea nitrogen [Mass/volume] in Serum or Plasma36mg/dL6-24 mg/dLHighS
2026-06-29Creatinine [Mass/volume] in Serum or Plasma2.4mg/dL0.74-1.35 mg/dLHighS
2026-06-29Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M30mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
2026-06-29Glucose [Mass/volume] in Serum or Plasma96mg/dL70-99 mg/dLNormalS
2026-06-29Albumin/Creatinine [Mass Ratio] in Urine360mg/g<=30 mg/gHighS
2026-10-26Sodium [Moles/volume] in Serum or Plasma136mmol/L135-145 mmol/LNormalS
2026-10-26Potassium [Moles/volume] in Serum or Plasma4.5mmol/L3.5-5.1 mmol/LNormalS
2026-10-26Carbon dioxide, total [Moles/volume] in Serum or Plasma23mmol/L22-29 mmol/LNormalS
2026-10-26Urea nitrogen [Mass/volume] in Serum or Plasma34mg/dL6-24 mg/dLHighS
2026-10-26Creatinine [Mass/volume] in Serum or Plasma2.3mg/dL0.74-1.35 mg/dLHighS
2026-10-26Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M32mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
2026-10-26Glucose [Mass/volume] in Serum or Plasma93mg/dL70-99 mg/dLNormalS
2026-10-26Calcium [Mass/volume] in Serum or Plasma9.2mg/dL8.6-10.3 mg/dLNormalS
2026-10-26Phosphate [Mass/volume] in Serum or Plasma4mg/dL2.5-4.5 mg/dLNormalS
2026-10-26Parathyrin.intact [Mass/volume] in Serum or Plasma78pg/mL15-65 pg/mLHighS
2026-10-26Hemoglobin [Mass/volume] in Blood12.8g/dL13.2-16.6 g/dLLowS
2026-10-26Albumin/Creatinine [Mass Ratio] in Urine240mg/g<=30 mg/gHighS
2026-10-26Kidney failure 2-year risk [Likelihood] by KFRE6.5%S
2026-10-26Kidney failure 5-year risk [Likelihood] by KFRE18.8%S
2026-10-26Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S
2026-05-11Left ventricular Ejection fraction60%50-70%NormalS
2026-08-10Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
2026-08-10Potassium [Moles/volume] in Serum or Plasma4.7mmol/L3.5-5.1 mmol/LNormalS
2026-08-10Carbon dioxide, total [Moles/volume] in Serum or Plasma23mmol/L22-29 mmol/LNormalS
2026-08-10Urea nitrogen [Mass/volume] in Serum or Plasma37mg/dL6-24 mg/dLHighS
2026-08-10Creatinine [Mass/volume] in Serum or Plasma2.4mg/dL0.74-1.35 mg/dLHighS
2026-08-10Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M30mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
2026-08-10Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-09-21Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S
2026-09-21Total score [AUDIT-C]1{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-05-04Body height170cmS
2026-05-04Body weight71kgS
2026-05-04Body mass index (BMI) [Ratio]24.6kg/m2S
2026-05-04Systolic blood pressure212mm[Hg]S
2026-05-04Diastolic blood pressure128mm[Hg]S
2026-05-04Heart rate88/minS
2026-05-04Respiratory rate16/minS
2026-05-04Body temperature36.8CelS
2026-05-04Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-05-11Body height170cmS
2026-05-11Body weight71kgS
2026-05-11Body mass index (BMI) [Ratio]24.6kg/m2S
2026-05-11Systolic blood pressure172mm[Hg]S
2026-05-11Diastolic blood pressure104mm[Hg]S
2026-05-11Heart rate82/minS
2026-05-11Respiratory rate16/minS
2026-05-11Body temperature36.7CelS
2026-05-11Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-06-01Body height170cmS
2026-06-01Body weight70kgS
2026-06-01Body mass index (BMI) [Ratio]24.2kg/m2S
2026-06-01Systolic blood pressure148mm[Hg]S
2026-06-01Diastolic blood pressure92mm[Hg]S
2026-06-01Heart rate78/minS
2026-06-01Respiratory rate16/minS
2026-06-01Body temperature36.8CelS
2026-06-01Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-06-29Body height170cmS
2026-06-29Body weight70kgS
2026-06-29Body mass index (BMI) [Ratio]24.2kg/m2S
2026-06-29Systolic blood pressure128mm[Hg]S
2026-06-29Diastolic blood pressure80mm[Hg]S
2026-06-29Heart rate74/minS
2026-06-29Respiratory rate14/minS
2026-06-29Body temperature36.7CelS
2026-06-29Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-10-26Body height170cmS
2026-10-26Body weight70.5kgS
2026-10-26Body mass index (BMI) [Ratio]24.4kg/m2S
2026-10-26Systolic blood pressure118mm[Hg]S
2026-10-26Diastolic blood pressure76mm[Hg]S
2026-10-26Heart rate72/minS
2026-10-26Respiratory rate14/minS
2026-10-26Body temperature36.6CelS
2026-10-26Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-08-10Body height170cmS
2026-08-10Body weight70.3kgS
2026-08-10Body mass index (BMI) [Ratio]24.3kg/m2S
2026-08-10Systolic blood pressure132mm[Hg]S
2026-08-10Diastolic blood pressure82mm[Hg]S
2026-08-10Heart rate80/minS
2026-08-10Respiratory rate14/minS
2026-08-10Body temperature36.7CelS
2026-08-10Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-09-21Body height170cmS
2026-09-21Body weight70.4kgS
2026-09-21Body mass index (BMI) [Ratio]24.4kg/m2S
2026-09-21Systolic blood pressure122mm[Hg]S
2026-09-21Diastolic blood pressure76mm[Hg]S
2026-09-21Heart rate72/minS
2026-09-21Respiratory rate14/minS
2026-09-21Body temperature36.6CelS
2026-09-21Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
2026-05-04Primary care visit for headaches, fatigue, and a very high blood pressurefinishedS
2026-05-11One-week blood pressure and kidney safety check with nephrology consultationfinishedS
2026-06-01Three-week check after losartan titration and dapagliflozin startfinishedS
2026-06-29Four-week check after adding chlorthalidonefinishedS
2026-10-26Six-month blood pressure and chronic kidney disease reviewfinishedS
2026-08-10Same-day sick visit for low back painfinishedS
2026-09-21Periodic adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Treat severe hypertension without acute target-organ damage as an outpatient: start losartan and amlodipine together, check home blood pressure twice daily, and go to the emergency department for chest pain, shortness of breath, weakness, confusion, or vision losscompletedGL-HTN-2025S
Nephrology referral for eGFR below 60 with severely increased albuminuria (UACR above 300 mg/g) and stage 2 hypertensioncompletedGL-KDIGO-CKD-2024, GL-CMID-2026S
Titrate losartan to the maximum tolerated dose and add an SGLT2 inhibitor for CKD with UACR of at least 200 mg/g; accept a creatinine rise of up to 30 percentcompletedGL-KDIGO-CKD-2024, GL-KDIGO-BP-2021S
Add chlorthalidone if blood pressure stays above target on two agents; avoid NSAIDs and review every medication dose for kidney functioncompletedGL-KDIGO-BP-2021, GL-HTN-2025S
Check potassium and creatinine one to four weeks after each renin-angiotensin, SGLT2 inhibitor, or diuretic change; then eGFR and UACR about three times a year for G3b A3, hemoglobin at least yearly, and calcium, phosphate, and PTH every six to twelve months; recalculate the kidney failure risk yearlycompletedGL-CMID-2026, GL-KDIGO-CKD-2024S
Moderate-intensity statin for an adult aged 50 or older with eGFR below 60; no routine repeat LDLcompletedGL-KDIGO-CKD-2024, GL-CMID-2026S
Sodium below 2 g a day with a plan for meals while traveling; at least 150 minutes of activity a weekcompletedGL-KDIGO-CKD-2024, GL-HTN-2025S
Annual dilated eye examination for hypertensive retinopathy; pneumococcal and hepatitis B vaccination for chronic kidney diseasecompletedGL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
Lower blood pressure below 130/80 within two months2026-06-29completedBlood pressure 128/80 on four medicinesS
Reach a standardized office systolic pressure below 120 when tolerated by the six-month review2026-10-26completedBlood pressure 118/76 without dizzinessS
Reduce the urine albumin-creatinine ratio by at least 30 percent by the six-month review2026-10-26completedUACR fell from 820 to 240 mg/gS
Keep eGFR decline after starting therapy within 30 percent and stable thereafter2026-10-26completedeGFR 36 at baseline, 30 on full therapy, 32 at six monthsS

Functional Status

Mental Status